Here's why some high-risk patients aren't getting drugs to combat COVID

by Emily Alpert Reyes, Los Angeles TimesCredit: Unsplash/CC0 Public DomainAs the toll from the COVID-19 pandemic continued to mount, antiviral medications such as Paxlovid were hailed by health offici

Updated on: May 26,2024 3

Here's why some high-risk patients aren't getting drugs to combat COVID

by Emily Alpert Reyes, Los Angeles TimesCredit: Unsplash/CC0 Public DomainAs the toll from the COVID-19 pandemic continued to mount, antiviral medications such as Paxlovid were hailed by health offici

Updated on:May 26,2024 3

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on: January 15,2024 10

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on:January 15,2024 10

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer

Updated on: January 04,2024 6

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer

Updated on:January 04,2024 6

How genetic therapies transformed the lives of sickle cell patients

Credit: CC0 Public DomainTheir stories are divided into before and after. First, those long years of pain which flooded every moment—school, relationships, work.And then—after agonizing treatments—wha

Updated on: March 27,2024 0

How genetic therapies transformed the lives of sickle cell patients

Credit: CC0 Public DomainTheir stories are divided into before and after. First, those long years of pain which flooded every moment—school, relationships, work.And then—after agonizing treatments—wha

Updated on:March 27,2024 0

COVID-19 antiviral treatment should be taken for longer, says study

by University College LondonViral and spike antibody dynamics in molnupiravir (purple) and Usual Care (gray) arms. a) Median viral load ±95%CI with time, below limit of quantification (BLOQ) meas

Updated on: May 11,2024 6

COVID-19 antiviral treatment should be taken for longer, says study

by University College LondonViral and spike antibody dynamics in molnupiravir (purple) and Usual Care (gray) arms. a) Median viral load ±95%CI with time, below limit of quantification (BLOQ) meas

Updated on:May 11,2024 6

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on: May 26,2024 3

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on:May 26,2024 3

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on: March 22,2024 12

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on:March 22,2024 12

Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors

byUniversity of Eastern FinlandSurvival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according

Updated on: January 25,2024 24

Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors

byUniversity of Eastern FinlandSurvival of the patients according to the risk scores. Kaplan-Meier curves illustrating overall survival (OS) (a) and progression-free survival (PFS) (b) according

Updated on:January 25,2024 24

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t

Updated on: January 26,2024 25

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t

Updated on:January 26,2024 25

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue

Updated on: January 26,2024 15

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue

Updated on:January 26,2024 15

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

Updated on: March 25,2024 17

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

Updated on:March 25,2024 17

Researchers find a common immune system mechanism between pregnancy and cancer

by Nicole Fawcett,University of MichiganCredit:Cell(2024). DOI: 10.1016/j.cell.2024.06.012To understand why some cancers successfully circumvent the immune system to grow unchecked,

Updated on: July 09,2024 0

Researchers find a common immune system mechanism between pregnancy and cancer

by Nicole Fawcett,University of MichiganCredit:Cell(2024). DOI: 10.1016/j.cell.2024.06.012To understand why some cancers successfully circumvent the immune system to grow unchecked,

Updated on:July 09,2024 0